Observational studyCommunications biology2026
Quinoa bioester application shifts human skin proteome toward molecular profiles associated with younger age.
Observational study in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Skin aging involves complex molecular changes that current strategies struggle to reverse. Here, we developed a machine learning approach using Support Vector Regression to predict biological skin age from proteomic profiles, enabling objective assessment of anti-aging formulations. In this exploratory, proof-of-concept, prospective observational study, we set out to characterize treatment-induced proteomic changes in human skin as the pre-specified primary outcome. Women (ages 20-80) received 30-day topical quinoa bioester application on one forearm, with the contralateral forearm receiving vehicle. Mass spectrometry revealed significant upregulation of barrier function proteins (desmoglein-1, filaggrin), antioxidant enzymes (SOD1, glutaredoxin-1), and protease inhibitors. Our Support Vector Regression (SVR) model, trained on pre-treatment proteomes, predicted lower proteomic ages for quinoa bioester-treated skin compared to vehicle-treated skin, with observed median differences of 11 and 16 years for participants under and over 50, respectively (p < 0.01 for participants ≥50 years). While these values do not necessarily correspond to biological years, these findings demonstrate that topical bioactives can induce detectable shifts in skin proteomic profiles. These results establish a quantitative framework for evaluating skin rejuvenation strategies and suggest quinoa bioester as a promising anti-aging cosmeceutical.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.